Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1100 of 1,261
  1. US 7122579

    Eye treatments using synthetic thyroid hormone compositions

    The Regents of the University of California · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  2. US 7118752

    Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I

    UNIVERSITY OF CONNECTICUT · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  3. US 7119064

    Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

    The Board of Regents of the University of Texas System · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  4. US 7118738

    Recombinant pox virus for immunization against MUC1 tumor-associated antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  5. US 7118919

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  6. US 7119223

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  7. US 7118873

    Polynucleotides encoding cellular transporters and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  8. US 7118758

    Transformed bacteria producing CS6 antigens as vaccines

    The United States of America as represented by the Secretary of the Army · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  9. US 7118746

    Conditioned cell culture medium compositions and methods of use

    SkinMedica, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  10. US 7118865

    Methods for diagnosing severe systemic lupus erythematosus

    Regents of the University of Minnesota · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  11. US 7118747

    AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

    Pacific Northwest Biotechnology Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  12. US 7119200

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  13. US 7119221

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  14. US 7119105

    Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

    The Regents of the University of California · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  15. US 7119066

    Modified ciliary neurotrophic factor (CNTF)

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  16. US 7119103

    β3-Adrenoreceptor agonists, agonist compositions and methods of using

    Molecular Design International, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  17. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  18. US 7115262

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  19. US 7115582

    HoxD3 and HoxA3 compositions and methods for improved wound healing

    The Regents of the University of California · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  20. US 7115560

    Methods for modulating gastric secretion using prokineticin receptor antagonists

    The Regents of the University of California · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  21. US 7115360

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  22. US 7115577

    Colorectal neoplasia prophylaxis

    The Board of Regents of the University of Texas System · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  23. US 7115405

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  24. US 7115260

    Interleukin-1β converting enzyme like apoptotic protease-6

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.